Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2000 Feb;37(2):108–113. doi: 10.1136/jmg.37.2.108

Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer

K Aktan-Collan 1, J Mecklin 1, A de la Chapelle 1, P Peltomaki 1, A Uutela 1, H Kaariainen 1
PMCID: PMC1734517  PMID: 10662810

Abstract

OBJECTIVES—To evaluate the feasibility of a reduced counselling programme for predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC) in terms of counsellees' opinions on the extent and significance of genetic counselling and need for psychological support at different phases of the testing procedure.
DESIGN—Prospective follow up study with pre-test questionnaire assessment of background sociodemographic variables. The protocol comprised a pre-test counselling session, a period for reflection, and a test disclosure session. The outcome variables were studied by post-test questionnaires at one month and one year follow up.
SUBJECTS—Two hundred and seventy one high risk members of 36 families with HNPCC who attended both counselling sessions and completed the questionnaires.
RESULTS—The pre-test counselling was considered fairly or very useful by 89% of respondents and one post-test session was considered sufficient by over 80% of respondents at follow up. Fifty three percent would have used extra psychological support had it been offered with the counselling. On enquiry one year after receiving the test result, only 2% stated that the need for support was at its greatest at that time, while the majority (46%) reported that the need for support had been greatest at the moment of test disclosure.
CONCLUSIONS—A protocol that includes one comprehensive pre-test counselling session and a test disclosure session, supplemented with the option of professional psychological support, seems to be sufficient for both the educational and supportive needs of counsellees. Only a minority expressed a need for post-test follow up sessions, which suggests that, in this disorder, resources can be directed to the beneficial surveillance programmes rather than to extensive psychological support.


Keywords: predictive genetic testing; genetic counselling; HNPCC; hereditary non-polyposis colorectal cancer

Full Text

The Full Text of this article is available as a PDF (138.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen L. A., Salovaara R., Kristo P., Canzian F., Hemminki A., Peltomäki P., Chadwick R. B., Käriäinen H., Eskelinen M., Järvinen H. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998 May 21;338(21):1481–1487. doi: 10.1056/NEJM199805213382101. [DOI] [PubMed] [Google Scholar]
  2. Benjamin C. M., Adam S., Wiggins S., Theilmann J. L., Copley T. T., Bloch M., Squitieri F., McKellin W., Cox S., Brown S. A. Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet. 1994 Oct;55(4):606–617. [PMC free article] [PubMed] [Google Scholar]
  3. Bloch M., Fahy M., Fox S., Hayden M. R. Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet. 1989 Feb;32(2):217–224. doi: 10.1002/ajmg.1320320215. [DOI] [PubMed] [Google Scholar]
  4. Cheuvront B., Sorensen J. R., Callanan N. P., Stearns S. C., DeVellis B. M. Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives. Am J Med Genet. 1998 Feb 17;75(5):461–468. [PubMed] [Google Scholar]
  5. Collins F. S. BRCA1--lots of mutations, lots of dilemmas. N Engl J Med. 1996 Jan 18;334(3):186–188. doi: 10.1056/NEJM199601183340311. [DOI] [PubMed] [Google Scholar]
  6. Dudok deWit A. C., Duivenvoorden H. J., Passchier J., Niermeijer M. F., Tibben A. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup. Psychosom Med. 1998 Sep-Oct;60(5):543–549. doi: 10.1097/00006842-199809000-00005. [DOI] [PubMed] [Google Scholar]
  7. DudokdeWit A. C., Tibben A., Duivenvoorden H. J., Frets P. G., Zoeteweij M. W., Losekoot M., van Haeringen A., Niermeijer M. F., Passchier J. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. J Med Genet. 1997 May;34(5):382–390. doi: 10.1136/jmg.34.5.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harper P. S. What do we mean by genetic testing? J Med Genet. 1997 Sep;34(9):749–752. doi: 10.1136/jmg.34.9.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Järvinen H. J., Mecklin J. P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995 May;108(5):1405–1411. doi: 10.1016/0016-5085(95)90688-6. [DOI] [PubMed] [Google Scholar]
  10. Kessler S. Predictive testing for Huntington disease: a psychologist's view. Am J Med Genet. 1994 Sep 15;54(3):161–166. doi: 10.1002/ajmg.1320540302. [DOI] [PubMed] [Google Scholar]
  11. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18;87(2):159–170. doi: 10.1016/s0092-8674(00)81333-1. [DOI] [PubMed] [Google Scholar]
  12. Lerman C., Biesecker B., Benkendorf J. L., Kerner J., Gomez-Caminero A., Hughes C., Reed M. M. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997 Jan 15;89(2):148–157. doi: 10.1093/jnci/89.2.148. [DOI] [PubMed] [Google Scholar]
  13. Lerman C., Hughes C., Trock B. J., Myers R. E., Main D., Bonney A., Abbaszadegan M. R., Harty A. E., Franklin B. A., Lynch J. F. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA. 1999 May 5;281(17):1618–1622. doi: 10.1001/jama.281.17.1618. [DOI] [PubMed] [Google Scholar]
  14. Lerman C., Narod S., Schulman K., Hughes C., Gomez-Caminero A., Bonney G., Gold K., Trock B., Main D., Lynch J. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996 Jun 26;275(24):1885–1892. [PubMed] [Google Scholar]
  15. Lynch H. T., Drouhard T., Vasen H. F., Cavalieri J., Lynch J., Nord S., Smyrk T., Lanspa S., Murphy P., Whelan K. L. Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer. 1996 Jan 1;77(1):30–35. doi: 10.1002/(SICI)1097-0142(19960101)77:1<30::AID-CNCR7>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  16. Lynch H. T., Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer. 1996 Sep 15;78(6):1149–1167. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  17. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  18. Nyström-Lahti M., Kristo P., Nicolaides N. C., Chang S. Y., Aaltonen L. A., Moisio A. L., Järvinen H. J., Mecklin J. P., Kinzler K. W., Vogelstein B. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med. 1995 Nov;1(11):1203–1206. doi: 10.1038/nm1195-1203. [DOI] [PubMed] [Google Scholar]
  19. Nyström-Lahti M., Wu Y., Moisio A. L., Hofstra R. M., Osinga J., Mecklin J. P., Järvinen H. J., Leisti J., Buys C. H., de la Chapelle A. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet. 1996 Jun;5(6):763–769. doi: 10.1093/hmg/5.6.763. [DOI] [PubMed] [Google Scholar]
  20. Ponder B. Genetic testing for cancer risk. Science. 1997 Nov 7;278(5340):1050–1054. doi: 10.1126/science.278.5340.1050. [DOI] [PubMed] [Google Scholar]
  21. Resta Robert G. The twisted helix: an essay on genetic counselors, eugenics, and social responsibility. J Genet Couns. 1992 Sep;1(3):227–243. doi: 10.1007/BF00961584. [DOI] [PubMed] [Google Scholar]
  22. Sorenson J. R., Cheuvront B., DeVellis B., Callanan N., Silverman L., Koch G., Sharp T., Fernald G. Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. Am J Med Genet. 1997 May 16;70(2):121–129. [PubMed] [Google Scholar]
  23. Tibben A., Frets P. G., van de Kamp J. J., Niermeijer M. F., Vegtervan der Vlis M., Roos R. A., Rooymans H. G., van Ommen G. J., Verhage F. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. Am J Med Genet. 1993 Jul 15;48(2):103–111. doi: 10.1002/ajmg.1320480209. [DOI] [PubMed] [Google Scholar]
  24. Tibben A., Vegter-van der Vlis M., Skraastad M. I., Frets P. G., van der Kamp J. J., Niermeijer M. F., van Ommen G. J., Roos R. A., Rooijmans H. G., Stronks D. DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects. Am J Med Genet. 1992 Sep 1;44(1):94–99. doi: 10.1002/ajmg.1320440122. [DOI] [PubMed] [Google Scholar]
  25. Vernon S. W., Gritz E. R., Peterson S. K., Amos C. I., Perz C. A., Baile W. F., Lynch P. M. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 1997 Jan;16(1):73–86. doi: 10.1037//0278-6133.16.1.73. [DOI] [PubMed] [Google Scholar]
  26. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES